4.7 Article

A comparison of accurate automatic hippocampal segmentation methods

Journal

NEUROIMAGE
Volume 155, Issue -, Pages 383-393

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2017.04.018

Keywords

Hippocampal segmentation; Alzheimer's disease; Dice's kappa; Cohen's d; Area under receiver operating characteristic curve

Funding

  1. Canadian Institutes of Health Research [MOP-111169]
  2. les Fonds de Research Sante Quebec Pfizer Innovation fund [25262]
  3. NSERC CREATE [4140438 - 2012]
  4. Famille Louise Andre Charron
  5. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  6. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  7. National Institute on Aging
  8. National Institute of Biomedical Imaging and Bioengineering
  9. AbbVie
  10. Alzheimer's Association
  11. Alzheimer's Drug Discovery Foundation
  12. Araclon Biotech
  13. BioClinica, Inc.
  14. Biogen
  15. Bristol-Myers Squibb Company
  16. CereSpir, Inc.
  17. Cogstate
  18. Eisai, Inc.
  19. Elan Pharmaceuticals, Inc.
  20. Eli Lilly and Company
  21. EuroImmun
  22. F. Hoffmann-La Roche Ltd
  23. Genentech, Inc.
  24. Fujirebio
  25. GE Healthcare
  26. IXICO Ltd.
  27. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  28. Johnson & Johnson Pharmaceutical Research & Development, LLC.
  29. Lumosity
  30. Lundbeck
  31. Merck Co., Inc.
  32. Meso Scale Diagnostics, LLC.
  33. NeuroRx Research
  34. Neurotrack Technologies
  35. Novartis Pharmaceuticals Corporation
  36. Pfizer, Inc.
  37. Piramal Imaging
  38. Servier
  39. Takeda Pharmaceutical Company
  40. Transition Therapeutics
  41. Canadian Institutes of Health Research
  42. Canada Foundation for Innovation (CFI)
  43. ministere de l'Economie, de la Science et de l'Innovation du Quebec (MESI)
  44. Fonds de recherche du Quebec - Nature et technologies (FRQ-NT)

Ask authors/readers for more resources

The hippocampus is one of the first brain structures affected by Alzheimer's disease (AD). While many automatic methods for hippocampal segmentation exist, few studies have compared them on the same data. In this study, we compare four fully automated hippocampal segmentation methods in terms of their conformity with manual segmentation and their ability to be used as an AD biomarker in clinical settings. We also apply error correction to the four automatic segmentation methods, and complete a comprehensive validation to investigate differences between the methods. The effect size and classification performance is measured for AD versus normal control (NC) groups and for stable mild cognitive impairment (sMCI) versus progressive mild cognitive impairment (pMCI) groups. Our study shows that the nonlinear patch-based segmentation method with error correction is the most accurate automatic segmentation method and yields the most conformity with manual segmentation (kappa = 0.894). The largest effect size between AD versus NC and sMCI versus pMCI is produced by FreeSurfer with error correction. We further show that, using only hippocampal volume, age, and sex as features, the area under the receiver operating characteristic curve reaches up to 0.8813 for AD versus NC and 0.6451 for sMCI versus pMCI. However, the automatic segmentation methods are not significantly different in their performance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available